Global University Venturing

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Caroline Dreyer, leader of Conectus, has been appointed president of the national Satt Network for a one-year term as part of a board reshuffle.

Born out of the Stanford Virtual Human Interaction Lab, Strivr uses virtual reality to train athletes and employees and has now collected $51m in funding altogether.

Based on research at Grousbeck Gene Therapy Center and Massachusetts Eye and Ear, Affinia has raised $60m in a series A round to advance its gene therapies into the clinic.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Invesco will sell its unquoted UK holdings to reallocate its capital to public stocks, meaning disruption for numerous spinouts and Oxford Sciences Innovation.

Bpifrance supplied funding through three separate units to help take Satt Conectus-allied rare disease drug developer Dynacure's latest round to $55m.

Zucara Therapeutics, a diabetes treatment developer exploiting University of Toronto intellectual property, will use the money for phase 1 and 2 trials.

AristaMD, developer of a remote diagnostics system, raised $18m in a round backed by CU Healthcare Innovation Fund.

Niantic has purchased University of Oxford’s augmented reality engine developer 6D.ai and will use the spinout’s technology for large-scale mapping for its games.

Twaice, a TUM spinout that provides predictive analytics to battery manufacturers, secured the return of UVC Partners to bring its funding haul to $15.7m.